Advertisement

Topics

Minerva Pharmaceuticals Company Profile

01:47 EDT 24th June 2018 | BioPortfolio

Minerva Pharmaceuticals, Inc. is a biopharmaceutical product development company dedicated to detecting and eliminating cancer before clinical symptoms occur.

Location

Technology Development Center1414 Key Highway
Baltimore
MD
21230
United States of America

Contact

Phone: 410.752.2221
Fax: 410.752.2456
Email: info@minervapharmaceuticals.com


News Articles [506 Associated News Articles listed on BioPortfolio]

Minerva Neurosciences, Inc.: Minerva Neurosciences Names Remy Luthringer as Executive Chairman and William Doyle as Lead Independent Director

WALTHAM, Mass., 2018-02-05 14:30 CET (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a biopharmaceutical company focused on the development of therapies to treat central nervous syst...

Minerva Neurosciences, Inc.: Minerva Neurosciences to Report Fiscal 2017 Fourth Quarter and Year End Financial Results and Business Updates on March 12, 2018

Management to host conference call WALTHAM, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the developme...

Minerva API Insight,2018 [Report Updated: 14022018] Prices from USD $500

IntroductionDelveInsight's, Minerva API Insight, 2018 report provides product and API manufacturers' details across the globe along with the location. The report gives the clear idea on the country w...

Minerva Neurosciences, Inc.: Minerva Neurosciences Reports Fiscal 2017 Fourth Quarter and Year End Financial Results and Business Updates

Four late-stage trials underway, targeting schizophrenia, major depressive disorder and insomnia disorder Planning for commercialization moves forward Management to host conference call today at 8...

Surgical device firm demands the retraction of a study paid for by its rival

Minerva Surgical demanded the immediate retraction of a recent study showing that rival Hologic’s device for endometrial ablation is better than Minerva’s, alleging the paper makes "misleading sta...

Minerva Neurosciences to Present at Jefferies 2018 Global Healthcare Conference on June 6, 2018

WALTHAM, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to trea...

Investor Network: Minerva Neurosciences Inc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 12, 2018 / Minerva Neurosciences Inc (NASDAQ: NERV) will be discussing their earnings results in their Q4 Earnings Call to be held on March 12, 2018 at 8:30 AM Eas...

MIN-101 (Minerva Neurosciences/Mitsubishi Tanabe) Drug Overview 2017/2018-2026: A Novel Antagonist of the Sigma-2 and Serotonin 5-HT2A Receptors – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Drug Overview: MIN-101” report has been added to ResearchAndMarkets.com’s offering. MIN-101 (Minerva Neurosciences/Mitsubishi Tanabe) is a nov...

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [189 Associated PubMed Articles listed on BioPortfolio]

A year in review in Minerva Anestesiologica 2017 Critical Care: experimental and clinical studies.

Alfalfa and Pastures: Sources of Pests or Generalist Natural Enemies?

Pierce's disease of grapevine and almond leaf scorch disease are both caused by the bacterial pathogen Xylella fastidiosa Wells et al. In the Central Valley of California, Draeculacephala minerva Ball...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

Clinical Trials [219 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1325 Associated Companies listed on BioPortfolio]

Minerva Pharmaceuticals

Minerva Pharmaceuticals, Inc. is a biopharmaceutical product development company dedicated to detecting and eliminating cancer before clinical symptoms occur.

Minerva Biotechnologies

Minerva Biotechnologies is a pioneer in the field of stem cells and cancer stem cells. Minerva was first to discover that cancer cells hijack an otherwise normal stem cell growth ...

Minerva Biolabs GmbH

Minerva Biolabs is committed to providing highest quality in products and services.1999 The company was established in August 1999 as a spin-off from the Robert-Koch Institute (RKI) in Berlin. Minerva...

Minerva Holdings Inc.

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

More Information about "Minerva Pharmaceuticals" on BioPortfolio

We have published hundreds of Minerva Pharmaceuticals news stories on BioPortfolio along with dozens of Minerva Pharmaceuticals Clinical Trials and PubMed Articles about Minerva Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Minerva Pharmaceuticals Companies in our database. You can also find out about relevant Minerva Pharmaceuticals Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record